Clinical Trial

Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer

Name: Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer — clinical trial record (NCT07645391)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This study evaluates urinary biomarkers and PSA to help determine the best approach to early detection of prostate cancer in patients with an elevated familial risk.

Trial Details

NCT Number	NCT07645391
Lead Sponsor	University of Michigan Rogel Cancer Center Collaborators: National Cancer Institute (NCI)
Conditions	Prostate Carcinoma
Enrollment	200 participants
Start Date	2017-01-01
Primary Completion	2030-01 (estimated)
Study Completion	2030-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-12